Lineage Cell Therapeutics (LCTX) – Genentech Licensing Agreement For OpRegen Begins Transformation

Tuesday, December 21, 2021

Lineage Cell Therapeutics (LCTX)
Genentech Licensing Agreement For OpRegen Begins Transformation

Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. With this platform Lineage develops and manufactures specialized, terminally differentiated human cells from its pluripotent and progenitor cell starting materials. These differentiated cells are developed to either replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer. Lineage’s clinical programs are in markets with billion dollar opportunities and include three allogeneic (“off-the-shelf”) product candidates: (i) OpRegen®, a retinal pigment epithelium transplant therapy in Phase 1/2a development for the treatment of dry age-related macular degeneration, a leading cause of blindness in the developed world; (ii) OPC1, an oligodendrocyte progenitor cell therapy in Phase 1/2a development for the treatment of acute spinal cord injuries; and (iii) VAC, an allogeneic dendritic cell therapy platform for immuno-oncology and infectious disease, currently in clinical development for the treatment of non-small cell lung cancer. For more information, please visit www.lineagecell.com or follow the Company on Twitter @LineageCell.

Robert LeBoyer, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    OpRegen Licensing and Collaboration With Genentech Announced.  Lineage Cell and Genentech/Roche (RHHBY, $50.89, Not Rated) announced a licensing agreement covering OpRegen, the retinal pigment epithelial (RPE) cell transplant currently in Phase 1/2a development. Under the agreement Genentech will assume responsibilities and expenses for developing OpRegen through commercialization in exchange for $50 million in upfront payments, $620 million in milestones, and royalties on sales.

    Financial Terms Include $50 Million in Up-Front Payments Plus $620 Million in Milestones and Sales Royalties.  The agreement includes an up-front signing fee of $50 million plus undisclosed milestone payments of up to $620 million, and double-digit royalties on sales. Lineage Cell is obligated to make payments to the originators of the technology, which we estimate to be about $22 million, for net …



This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision. 

FAT Brands Inc. (FAT) – Acquisition Closings; New Store Openings

Tuesday, December 21, 2021

FAT Brands Inc. (FAT)
Acquisition Closings; New Store Openings

FAT Brands Inc is a multi-brand restaurant franchising company. It develops, markets, and acquires predominantly fast casual restaurant concepts. The company provides turkey burgers, chicken Sandwiches, chicken tenders, burgers, ribs, wrap sandwiches, and others. Its brand portfolio comprises Fatburger, Buffalo’s Cafe and Express, and Ponderosa and Bonanza. The company’s overall footprint covers nearly 32 countries. Fatburger generates maximum revenue for the company.

Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    Fazoli’s and Native Grill. FAT Brands has completed the acquisitions of Italian QSR Fazoli’s and wing concept Native Grill. We anticipate both concepts to see attractive growth. Fazoli’s had an outstanding year with three quarters of record setting sales in 2021, while Native Grill further complements FAT Brands’ existing wing concepts and provides FAT Brands with a larger footprint on the West Coast.

    Arkansas Debut.  Earlier this month, FAT announced the opening of a new co-branded Fatburger and Buffalo’s Express in Greenbrier, Arkansas, under a deal finalized in early 2021. As we have noted in past reports, organic growth is a no cost path for incremental sales and EBITDA growth for FAT Brands …



This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision. 

BioSig Technologies, Inc. Selects Access Strategy Partners to Accelerate Commercial Sales



BioSig Technologies, Inc. Selects Access Strategy Partners to Accelerate Commercial Sales

News and Market Data on BioSig Technologies

 

Leading healthcare management firm to enhance the Company’s market access strategy as it expands the installation base of its signal processing technology for arrhythmia care

Westport, CT, Dec. 21, 2021 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that it appointed Access Strategy Partners, Inc. to advise on the next phase of the commercial roll-out.

Led by medical device sales experts, Boston-based Access Strategy Partners brings to BioSig deep expertise in commercialization, contract management, execution, and value proposition optimization. The company’s Co-Founder and President, Jim Walker, is a healthcare executive with more than 30 years of experience in sales, marketing, sales operations, and national accounts management in some of the leading companies in the medical device sector, including Boston Scientific Corporation (BSC) and Johnson & Johnson. His experience spans domestic and international responsibilities, focusing on strategic market development and key customer management. During his 18-year career with Boston Scientific Corporation, Mr. Walker established the organization as a recognized leader with Group Purchasing Organizations. He created a world-class Corporate Sales organization that represented the full BSC portfolio to supply chain executives across every level of market aggregation, including group purchasing organizations (GPOs), national and regional integrated delivery networks (IDNs), and National and Regional Purchasing Alliances. Mr. Walker was the company’s lead strategic pricing advisor and gained the support of the executive management team to invest in and develop an enterprise-wide contract management system that provides global pricing intelligence and profitability analysis capabilities.

“ASPI was founded to provide strategic relationship management for emerging medical device companies,” said Jim Walker. “Our sales conversations are all about delivering excellent clinical and economic value. BioSig and its breakthrough PURE EP(TM) product bring meaningful benefits to physicians and patients that we are thrilled to introduce to healthcare providers.”

Under the terms of the new collaboration, Access Strategy Partners will advise BioSig on all aspects of commercial strategy, including economic value modeling, hospital administration engagement, and contracting.

“Jim and his highly accomplished team at Access Strategy Partners brings us proven success strategies in accelerating commercialization. Look closely at ASPI’s track record in helping emerging medical device companies, and you will see what we saw – strong revenue growth rates with sustainability. We look forward to learning from some of the brightest minds in medical device sales as we leverage the key insights from our initial commercial efforts to bring our disruptive technology to the next level of hospitals nationwide,” commented Kenneth L. Londoner, Chairman, and CEO of BioSig Technologies, Inc.

The PURE EP(TM) is an FDA 510(k) cleared non-invasive class II device that aims to drive procedural efficiency and efficacy in cardiac electrophysiology. To date, over 70 physicians have completed over 1750 patient cases with the PURE EP(TM) System.

Clinical data acquired by the PURE EP(TM) System in a multi-center study at Texas Cardiac Arrhythmia Institute at St. David’s Medical Center, Mayo Clinic Jacksonville and Massachusetts General Hospital was recently published in the Journal of Cardiovascular Electrophysiology and is available electronically with open access via the Wiley Online Library. Study results showed 93% consensus across the blinded reviewers with a 75% overall improvement in intracardiac signal quality and confidence in interpreting PURE EP(TM)  signals over conventional sources.

The Company recently appointed a former Abbott senior sales leader Mr. Gray Fleming as its Chief Commercial Officer. BioSig is in a targeted commercial launch of the PURE EP(TM) System in the Northeast, Texas, and Florida and is in regular use in some of the country’s leading centers of excellence, including the Mayo Clinic in Rochester, MN, and St. David’s Medical Center in Austin, TX.

About BioSig Technologies
BioSig Technologies is a medical technology company commercializing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals (www.biosig.com).

The Company’s first product, PURE EP(TM) System is a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording, and storing electrocardiographic and intracardiac signals for patients undergoing electrophysiology (EP) procedures in an EP laboratory.

Forward-looking Statements
This press release contains “forward-looking statements.” Such statements may be preceded by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. Forward- looking statements are not guarantees of future performance, are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company’s control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) the geographic, social and economic impact of COVID-19 on our ability to conduct our business and raise capital in the future when needed, (ii) our inability to manufacture our products and product candidates on a commercial scale on our own, or in collaboration with third parties; (iii) difficulties in obtaining financing on commercially reasonable terms; (iv) changes in the size and nature of our competition; (v) loss of one or more key executives or scientists; and (vi) difficulties in securing regulatory approval to market our products and product candidates. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company’s filings with the Securities and Exchange Commission (SEC), including the Company’s Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC’s website at http://www.sec.gov. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise.


Andrew Ballou
BioSig Technologies, Inc.
Vice President, Investor Relations
55 Green Farms Road
Westport, CT 06880, US
aballou@biosigtech.com
203-409-5444, x133

Source: BioSig Technologies, Inc.

Market Index Inclusion and Spikes in a Stock’s Demand


Image credit: Liza Summers (Pexels)

Why Investors and Stock Pickers Watch Russell Index Addition Dates

 

A sudden rise in a stock’s price is almost always demand-related. This could occur if the company beats earnings estimates, announces a breakthrough product, is being considered for acquisition from a larger company, or public policy shifts in their favor. Another reason could be inclusion in a major stock market index.

There are investors that look to determine which companies may be added to an index and which may be removed. Although being right doesn’t always mean huge gains for them, the rewards on average make this a legitimate approach for stock picking. One of the more common family of indexes that investors watch is the FTSE Russell indexes. The reason is these are more transparent than others. Russell actually puts out a calendar each year and shares its methodology for including new companies on its website.

The annual rejiggering of the Russell indexes, known as the Russell Reconstitution, is in late Spring and attracts a lot of attention.  Subscribers to Channelchek can expect to receive our notification and analysis on the small-cap Russell 2000 index reconstitution.

 

Abbreviated History of Impactful Companies Added to the Russell after their IPO

Russell updates its indexes quarterly to include new public companies to best represent the market.

 

In addition to the annual index reconstitution, FTSE Russell also has a quarterly calendar where they look at IPOs that occurred during the quarter and weigh the outcomes against their methodology for inclusion in the broad Russell 3000 index. Once in the 3000, companies may be further segmented into other indexes. These inclusions can alter the demand for the stock both immediately, as fund managers seek to mimic an index and buy the stock, and then over time, as index investor demand for the index funds ebb and flow.

 

 

As a testament to just how impactful these additions may be, a recent example involves a company called Society Pass, Inc. (SOPA). Society Pass went public via an IPO in November. On December 20th Russell added new IPOs in order to update the indexes to reflect current markets, and SOPA was added both to the Russell 3000 broad index and the Russell 2000. The average daily trading volume for SOPA leading up to the inclusion was 1.3M, on December 20th, 167.5M shares changed hands. The impact is indicated above in the month-to-date graph (% change). The stock opened at $4.44, traded as high as $13.48, and closed at $11.26. 

 

Opportunity in IPO Additions

Over the last ten years, there have been almost 1500 IPO additions to the Russell Indexes, and the Russell 2000 Small-Cap Index has had the majority of these additions.

 

 

After the Addition

Inclusion in a major index generally results in a higher “base price” for the stock. Further price changes are then more closely tied to fundamentals like company performance.   However, the stock will experience the added transactions that have very little to do with the company and are instead index expectation related. In addition, there should be higher trade volumes and possibly an even higher level of demand because of the company’s increased visibility.

Paul Hoffman

Managing Editor, Channelchek

 

Suggested Reading:



Peter Lynch Echoes Michael Burry’s Warning About Index Investments



The Russell Index Reconstitution, What to Know





Does the Russell Reconstitution Impact Small-Cap Performance During June?



Does Cathie Wood’s ESG Fund Have it Wrong?

 

Sources:

https://content.ftserussell.com/sites/default/files/final_ipo_additions_2021_4_qtr_r3000.pdf

https://www.sec.gov/fast-answers/answersindiceshtm.html

https://budgeting.thenest.com/mutual-funds-safe-against-bad-stock-crash-30572.html

https://content.ftserussell.com/sites/default/files/2021_09_russell_indexes_quarterly_ipo_update.pdf

 

Stay up to date. Follow us:

 

Bunker Hill Announces $50 Million Project Finance Package, Mine Purchase, And US EPA Settlement Agreement Amendment



Bunker Hill Announces $50 Million Project Finance Package, Mine Purchase, And US EPA Settlement Agreement Amendment

Research, News, and Market Data on Bunker Hill Mining

 

Bunker Hill to Host Live Interactive 6ix Summit on Wednesday, December 22 @ 11:00am ET / 8:00am PT

HIGHLIGHTS

  • $50 million term sheet executed with Sprott Private Resource Streaming and Royalty Corp (“SRSR”) outlining a proposed financing package to fund mine restart in stages:
    • $8 million Royalty Convertible Debenture: 9.0% debt convertible to 1.85% life of mine royalty to fund mine purchase, initial EPA payment and on-going engineering. Closing expected in January 2022
    • $5 million Convertible Debenture: 7.5% interest, repaid or convertible at CAD 0.30 per share, to fund further engineering to PFS level by beginning of Q2 2022. Closing expected in January 2022
    • Stream: up to $37 million for up to 10% of all metals produced until certain quantities delivered; up to 2% thereafter, to fund majority of restart capital from Q2 2022. Closing expected by early Q2 2022
  • The Company retains option to re-purchase 50% of Stream at 1.40x multiple of stream funding until 2025
  • Mine purchase: agreement executed for $5.4 million all-cash purchase from Placer Mining
  • EPA Settlement Agreement amendment: agreement executed with US EPA and IDEQ for deferral of $17 million of existing $19 million liability to be paid from free cash flow during 2024-2029

NEXT STEPS

  • Construction decision expected post detailed engineering and mine plan optimization by early Q2 2022
  • Prefeasibility Study concurrent with construction decision, incorporating the 59% increase in M&I resources
  • Further non-dilutive financing options being explored to minimize any equity financing requirement in 2022
  • TSX-V Listing Committee discussions ongoing; material balance sheet improvement supports application
  • Chairman Richard Williams interviewed live by Kai Hoffmann today at 5:30pm ET / 2:30pm PT on SF Live. Live broadcast and replay available at YouTube.com/soarfinancial or twitter.com/soarfinancial
  • Chairman Richard Williams, CEO Sam Ash and CFO David Wiens to host live interactive 6ix virtual investor event on Wednesday, December 22 at 11:00am ET / 8:00am PT. Investors are invited to register at: LINK ]

TORONTO, Dec. 20, 2021 (GLOBE NEWSWIRE) — Bunker Hill Mining Corp. (the “Company”) (CSE: BNKR; OTCQB: BHLL) is pleased to announce the achievement of its key short-term objectives, including the execution of a non-binding term sheet outlining a $50 million non-dilutive project finance package, the purchase of the Bunker Hill Mine, and the execution of a settlement agreement amendment with the US Environmental Protection Agency (“US EPA” or “EPA”). All figures in this news release are in US dollars unless otherwise stated.

Sam Ash, CEO, stated “We are exceedingly pleased to announce the accomplishment of our key objectives, most notably a proposed $50 million project finance package that we expect to provide the majority of our funding requirements in a non-dilutive manner. Together with the purchase of the mine and an amended settlement agreement with the EPA, a rapid restart of the prolific Bunker Hill Mine is now clearly within sight. This will provide enormous social and economic benefits to northern Idaho, significant returns for our shareholders, and allow us to honor our commitments to the EPA. We look forward to next steps, including advancement to a formal construction decision and the review of our revised TSX-V Exchange listing application”.

$50 MILLION PROJECT FINANCE PACKAGE

The Company has executed a non-binding term sheet with SRSR outlining a $50 million project finance package that the Company expects to fulfill the majority of its funding requirements to restart the mine and reach commercial production in mid-2023. The package consists of an $8 million Royalty Convertible Debenture, a $5 million Convertible Debenture, and a multi-metals Stream of up to $37 million.

Subject to settlement of definitive documentation with SRSR, the Company expects that $8 million will be advanced under the Royalty Convertible Debenture in January 2022. These proceeds will fund the purchase of the Bunker Hill Mine and near-term working capital requirements, including a $2 million payment to the EPA in January 2022 (see “EPA Settlement Agreement Amendment” section below). The Royalty Convertible Debenture will initially bear interest at an annual rate of 9.0%, payable in cash or shares at the Company’s option, until such time that SRSR elects to convert it into a Royalty, with such conversion option expiring at the earlier of advancement of the Stream or 18 months. In the event of conversion, the Royalty Convertible Debenture will cease to exist and the Company will grant a Royalty for 1.85% of life-of-mine gross revenue from mining claims considered to be historically worked, contiguous to current accessible underground development, and covered by the Company’s 2021 ground geophysical survey. A 1.35% rate will apply to claims outside of these areas. The Royalty Convertible Debenture will initially be secured by a share pledge of the Company’s operating subsidiary, until such time that a full security package is put in place. In the event of non-conversion, the principal of the Royalty Convertible Debenture will be repayable in cash.

Subject to settlement of definitive documentation with SRSR, the Company expects that an aggregate amount of $5 million will be advanced under the Convertible Debenture, also in January 2022. These proceeds will fund capital expenditures and working capital requirements in Q1 2022. The Convertible Debenture will bear interest at an annual rate of 7.5%, payable in cash or shares at the Company’s option, and a maturity of 18 months from the closing of the Royalty Convertible Debenture. Until the closing of the Stream, the Convertible Debenture is convertible into shares of the Company at a share price of CAD 0.30 per share. Alternatively, SRSR may elect to retire the Convertible Debenture with the cash proceeds of the Stream. The Company may elect to re-pay the Convertible Debenture early; if SRSR elects not to exercise its conversion option at such time, a minimum of 12 months of interest would apply.

SRSR has concluded its initial due diligence process, including a site visit to the Bunker Hill Mine and a detailed project review by third party engineering and geological consultants, and has obtained Investment Committee approval to fund the $8 million Royalty Convertible Debenture and $5 million Convertible Debenture.

Subject to SRSR internal approvals, further technical and other diligence (including confirmation of full project funding by an independent engineer appointed by SRSR), and satisfactory definitive documentation, the Company expects to close the Stream concurrent with a formal construction decision being made by early Q2 2022. A minimum of $27 million and a maximum of $37 million (the “Stream Amount”) will be made available under the Stream, at the Company’s option, once the conditions for availability of the Stream have been satisfied. Assuming the maximum funding of $37 million is drawn, the Stream would apply to 10% of payable metals sold until a minimum quantity of metal is delivered consisting of, individually, 55 million pounds of zinc, 35 million pounds of lead, and 1 million ounces of silver. Thereafter, the Stream would apply to 2% of payable metals sold. If the Company elects to draw less than $37 million under the Stream, the percentage and quantities of payable metals streamed will adjust pro-rata. The delivery price of streamed metals will be 20% of the applicable spot price.

The Company may buy back 50% of the Stream Amount at a 1.40x multiple of the Stream Amount between the second and third anniversary of the date of funding, and at a 1.65x multiple of the Stream Amount between the third and fourth anniversary of the date of funding. The Company will be permitted to incur additional indebtedness of $15 million and a cost over-run facility of $13 million from other financing counterparties.

Closing of the Royalty Convertible Debenture, Convertible Debenture, and Stream are conditional on the conclusion of a number of matters, including finalization of definitive documentation, regulatory and stock exchange approvals, and closing of the purchase of the Bunker Hill Mine.

PURCHASE OF THE BUNKER HILL MINE

With the execution of the EPA settlement agreement amendment and the expected receipt of $8 million proceeds from the Royalty Convertible Debenture, the Company has exercised its option to purchase the Bunker Hill Mine from Placer Mining Corp. and a definitive agreement has been signed by both parties. The terms of the purchase were modified to $5.4 million in cash, from $3.4 million of cash and $2.0 million of common shares in the Company.

Purchase of the mine consists of over 400 patented mining claims and 5,800 acres of private land, an ideal scenario with respect to permitting considerations. The extensive in-place infrastructure and significant mineral potential included in the acquisition positions Bunker Hill for a rapid restart, and a return to free cash flow generation with exceptional growth potential in can be considered the pre-eminent silver mining district in the world.

Closing of the transaction is expected in January 2022, concurrent with funding of the Royalty Convertible Debenture, approval of the transaction by Placer Mining Corp. shareholders, and satisfaction of other closing conditions.

EPA SETTLEMENT AGREEMENT AMENDMENT

The amended Settlement Agreement (the “Amendment”) between the Company, Idaho Department of Environmental Quality, US Department of Justice and US EPA modifies the payment schedule and payment terms for recovery of historical environmental response costs at Bunker Hill Mine by US EPA. A total of $19 million remains to be paid by the Company. The new payment schedule includes a $2 million payment to US EPA within 30 days of execution of this amendment. The remaining $17 million will be paid on the following dates:

Date Amount
November 1, 2024 $3,000,000
November 1, 2025 $3,000,000
November 1, 2026 $3,000,000
November 1, 2027 $3,000,000
November 1, 2028 $3,000,000
November 1, 2029 $2,000,000 plus accrued interest

The resumption of payments in 2024 were agreed in order to allow the Company to generate enough revenue from mining activities at the Bunker Hill Mine to address remaining payment obligations from free cash flow.

The Amendment includes an additional payment for outstanding water treatment costs that have been incurred over the period from 2018 through 2020. This $2.9 million payment will be made within 90 days of the execution of the Amendment. With the execution of the Amendment, the Company is now fully compliant with the terms of the Settlement Agreement.

In addition to the changes in payment terms and schedule, the Company has committed to securing Financial Assurance in the form of performance bonds or letters of credit deemed acceptable to the EPA. The Financial Assurance will total $17 million, corresponding to the Company’s obligations to be paid in the 2024-2029 period as outlined above, that can be drawn on by US EPA in the event of non-performance by the Company. The amount of the bonds will decrease over time as individual payments are made. If the Company does not post the Financial Assurance within 90 days of execution of the Amendment, it must issue an irrevocable letter of credit for $9 million. US EPA may draw on this letter of credit after an additional 90 days if the Company is unable to either put the Financial Assurance in place or make payment for the full $17 million of remaining historical cost recovery sums. In the event neither occurs, the terms of the initial Settlement Agreement will be reinstated.

The Company has concluded the negotiation of commercial terms with two counterparties for the full $17 million Financial Assurance, with finalization contingent on full project funding being in place, including the Stream.

The Settlement Agreement was reached in 2018 in order for the US EPA to gain confidence that it will be repaid for historical environmental response costs it incurred for Bunker Hill Mine. The costs up to that point had been unpaid by the owner of the mine since 1994. The Company agreed to become a Responsible Party for these liabilities in exchange for the US EPA and US Department of Justice eliminating all other potential historical environmental liabilities related to the mine, specifically all CERCLA- or Superfund-related liabilities. The inability of the Company to meet payment obligations, however, meant that until the signing of the Amendment, it was in arrears for $11 million in cost recovery payments and over $2.9 million in unpaid water treatment costs. As of today, the Company is now fully compliant with the terms of the Settlement Agreement with US EPA.

NEXT STEPS

With the approval by SRSR’s Investment Committee of the $8 million Royalty Convertible Debenture and $5 million Convertible Debenture (subject to finalization of definitive documentation and other conditions precedent), and the execution of the mine purchase option and Settlement Agreement amendment, the Company is focused on accelerating the sustainable restart of the mine to commercial production in mid-2023. This includes progressing detailed engineering and mine planning to PFS level, purchasing a process plant, confirming and securing remaining capital requirements (including funding of the Stream), and upgrading the Company’s listing to the TSX Venture Exchange.

Detailed engineering for full project restart is well underway with geotechnical, metallurgical optimization, plant design, electrical infrastructure, water treatment, and geotechnical paste studies progressing well. This technical work is expected to result in significant value creation and support a construction decision by early Q2 2022, concurrent with a Prefeasibility Study incorporating the recently announced 59% increase in Measured and Indicated.   Project completion and commercial production is anticipated to occur in the second half of 2023.

Together with its financial advisor, Cutfield Freeman & Co., the Company is evaluating alternatives to secure further non-dilutive funding of up to $15 million as a project finance facility and up to $13 million as a cost over-run facility, as permitted in the Company’s $50 million project financing package. This would minimize any equity financing requirements to fully fund the mine restart.

With the material balance sheet improvements effected by the transactions described in this news release, the Company has re-engaged with the TSX-V Listing Committee regarding its application for an upgrade of its listing from the CSE to the TSX Venture Exchange. This application is currently under review.

ABOUT BUNKER HILL MINING CORP.

Under new Idaho-based leadership the Bunker Hill Mining Corp, intends to sustainably restart and develop the Bunker Hill Mine as the first step in consolidating a portfolio of North American precious-metal assets with a focus on silver. Information about the Company is available on its website, www.bunkerhillmining.com, or within the SEDAR and EDGAR databases.

For additional information contact:

David Wiens, CFA

CFO & Corporate Secretary

+1 208 370 3665

ir@bunkerhillmining.com

CAUTIONARY STATEMENTS

Certain statements in this news release are forward-looking and involve a number of risks and uncertainties. Such forward-looking statements are within the meaning of that term in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, as well as within the meaning of the phrase ‘forward-looking information’ in the Canadian Securities Administrators’ National Instrument 51-102 – Continuous Disclosure Obligations. Forward-looking statements are not comprised of historical facts. Forward-looking statements include estimates and statements that describe the Company’s future plans, objectives or goals, including words to the effect that the Company or management expects a stated condition or result to occur. Forward-looking statements may be identified by such terms as “believes”, “anticipates”, “expects”, “estimates”, “may”, “could”, “would”, “will”, or “plan”. Since forward-looking statements are based on assumptions and address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although these statements are based on information currently available to the Company, the Company provides no assurance that actual results will meet management’s expectations. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. Forward looking information in this news release includes, but is not limited to, the Company’s intentions regarding: its objectives, goals or future plans and statements; completing the acquisition of the Bunker Hill Mine; closing the financing package as described herein with SRSR; the financing package with SRSR being sufficient for the purposes described herein; the Company’s ability to secure additional financing, whether dilutive or non-dilutive; the Company’s ability to progress detailed engineering of the Bunker Hill Mine; the Company’s ability to purchasing a processing plant; the Company’s ability to restart production at the Bunker Hill Mine; the Company’s ability to generate free cash flow from the Bunker Hill Mine; the Company’s ability to complete payments to the U.S. EPA from free cash flow generated from the Bunker Hill Mine; and the listing of the Company’s shares on the TSX-V . Factors that could cause actual results to differ materially from such forward-looking information include, but are not limited to: the ability to predict and counteract the effects of COVID-19 on the business of the Company, including but not limited to the effects of COVID-19 on the price of commodities, capital market conditions, restriction on labour and international travel and supply chains; the TSX-V not approving the listing of the Company’s shares on the TSX-V; failure to identify mineral resources; failure to convert estimated mineral resources to reserves; the inability to complete a feasibility study which recommends a production decision; the preliminary nature of metallurgical test results; the Company’s ability to restart and develop the Bunker Hill Mine and the risks of not basing a production decision on a feasibility study of mineral reserves demonstrating economic and technical viability, resulting in increased uncertainty due to multiple technical and economic risks of failure which are associated with this production decision including, among others, areas that are analyzed in more detail in a feasibility study, such as applying economic analysis to resources and reserves, more detailed metallurgy and a number of specialized studies in areas such as mining and recovery methods, market analysis, and environmental and community impacts and, as a result, there may be an increased uncertainty of achieving any particular level of recovery of minerals or the cost of such recovery, including increased risks associated with developing a commercially mineable deposit with no guarantee that production will begin as anticipated or at all or that anticipated production costs will be achieved; failure to commence production would have a material adverse impact on the Company’s ability to generate revenue and cash flow to fund operations; failure to achieve the anticipated production costs would have a material adverse impact on the Company’s cash flow and future profitability; delays in obtaining or failures to obtain required governmental, environmental or other project approvals; political risks; changes in equity markets; uncertainties relating to the availability and costs of financing needed in the future; the inability of the Company to budget and manage its liquidity in light of the failure to obtain additional financing, including the ability of the Company to complete the payments to the Placer Mining Corporation and the U.S. EPA pursuant to the terms of the agreement to acquire the Bunker Hill Mine; inflation; changes in exchange rates; fluctuations in commodity prices; delays in the development of projects; capital, operating and reclamation costs varying significantly from estimates and the other risks involved in the mineral exploration and development industry; the cost, timing and ability to implement ESG initiatives which may not be technically successful or economically viable; and those risks set out in the Company’s public documents filed on SEDAR. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.

Lisa Walker Joins Gevo as Assistant General Counsel



Lisa Walker Joins Gevo as Assistant General Counsel

Research, News, and Market Data on Gevo

 

ENGLEWOOD, Colo., Dec. 21, 2021 (GLOBE NEWSWIRE) — Gevo, Inc. (NASDAQ:GEVO), announced today that Lisa Walker has joined Gevo as Assistant General Counsel. Ms. Walker brings more than 25 years of experience in commercial contracts and negotiation, litigation management, marketing and trading, real estate transactions, liability and risk assessment, and asset acquisition and divestiture. Most recently, she served as Assistant General Counsel – Commercial Transactions Attorney at Kinder Morgan, Inc.

“I’d like to issue an enthusiastic welcome to Lisa,” said Geoff Williams, General Counsel. “She is a trading and marketing veteran in the energy commodity space, including the natural gas, crude and crude oil products, natural gas liquids, wholesale propane, power, and renewables sectors. She will bolster the legal team by reviewing, drafting, and negotiating commercial transactions.”

“I am very pleased to be joining Gevo,” said Ms. Walker. “I hope to be an essential collaborator in a wide variety of corporate legal matters and look forward to developing meaningful partnerships.”

About Gevo

Gevo’s mission is to transform renewable energy and carbon into energy-dense liquid hydrocarbons. These liquid hydrocarbons can be used for drop-in transportation fuels such as gasoline, jet fuel and diesel fuel, that when burned have potential to yield net-zero greenhouse gas emissions when measured across the full life cycle of the products. Gevo uses low-carbon renewable resource-based carbohydrates as raw materials, and is in an advanced state of developing renewable electricity and renewable natural gas for use in production processes, resulting in low-carbon fuels with substantially reduced carbon intensity (the level of greenhouse gas emissions compared to standard petroleum fossil-based fuels across their life cycle). Gevo also plans to take advantage of decarbonization via geological sequestration in the future. Gevo’s products perform as well or better than traditional fossil-based fuels in infrastructure and engines, but with substantially reduced greenhouse gas emissions. In addition to addressing the problems of fuels, Gevo’s technology also enables certain plastics, such as polyester, to be made with more sustainable ingredients. Gevo’s ability to penetrate the growing low-carbon fuels market depends on the price of oil and the value of abating carbon emissions that would otherwise increase greenhouse gas emissions.

Gevo believes that its proven, patented technology enabling the use of a variety of low-carbon sustainable feedstocks to produce price-competitive low-carbon products such as gasoline components, jet fuel and diesel fuel yields the potential to generate project and corporate returns that justify the build- out of a multi-billion-dollar business.

Gevo believes that the Argonne National Laboratory GREET model is the best available standard of scientific-based measurement for life cycle inventory or LCI.

Learn more at Gevo’s website: www.gevo.com

Forward-Looking Statements

Certain statements in this press release may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to a variety of matters, without limitation, including the hiring of Lisa Walker, the attributes of Gevo’s products, and other statements that are not purely statements of historical fact. These forward-looking statements are made on the basis of the current beliefs, expectations and assumptions of the management of Gevo and are subject to significant risks and uncertainty. Investors are cautioned not to place undue reliance on any such forward-looking statements. All such forward-looking statements speak only as of the date they are made, and Gevo undertakes no obligation to update or revise these statements, whether as a result of new information, future events or otherwise. Although Gevo believes that the expectations reflected in these forward-looking statements are reasonable, these statements involve many risks and uncertainties that may cause actual results to differ materially from what may be expressed or implied in these forward-looking statements. For a further discussion of risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of Gevo in general, see the risk disclosures in the Annual Report on Form 10-K of Gevo for the year ended December 31, 2020, and in subsequent reports on Forms 10-Q and 8-K and other filings made with the U.S. Securities and Exchange Commission by Gevo.

Gevo Investor and Media Contact

Heather L. Manuel

+1 720-418-0085

IR@gevo.com

Entravision Raises Over $2.1 Million for Children’s Miracle Network Hospitals


Entravision Raises Over $2.1 Million for Children’s Miracle Network Hospitals

 

 

SANTA MONICA, Calif.–(BUSINESS WIRE)– Entravision Communications Corporation (NYSE: EVC), a leading global media and marketing technology company, and Children’s Miracle Network® announced today that together they successfully raised over $2.1 million in the 14th Annual Radiothon event. The Radiothon with the theme “Un Millón Para Los Niños” (One Million for the Children) ran from December 9th through December 11th and was promoted across 34 of Entravision’s owned and operated broadcast stations.

“I would like to extend a sincere thank you to our listeners, personalities and teams at Entravision and Children’s Miracle Network Hospitals for their contributions to this year’s Radiothon,” said Jeffery Liberman, Entravision’s President and Chief Operating Officer. “Entravision takes pride in giving back to our local communities, and we are proud to again work hand-in-hand with Children’s Miracle Network Hospitals to further this mission. We are excited to continue this successful partnership in the future.”

“During a time when our hospitals are struggling with the many challenges brought on by the pandemic, our 14-year partnership with Entravision has proven to be invaluable,” said Danny Garcia, National Director Hispanic Media Partners for Children’s Miracle Network. “These funds will help ensure that local children’s hospitals across the country have the necessary resources to help kids in many communities. Entravision’s amazing team once again delivered by motivating their generous audience and making this Radiothon a total success. I can’t thank Entravision enough for helping us to make miracles happen for local kids!”

Entravision’s 72-hour 2021 Children’s Miracle Network® Radiothon coverage ran on 14 different radio programs, including Erazno y la ChokolataAlex “El Genio” Lucas and El Show del Raton! and El Show de Piolín. Entravision also promoted the Radiothon with a multimedia campaign starting December 2nd which included QR code embedded television and hourly radio promos, display banners, a custom website, social media posts and videos across Entravision Radio and Noticias Ya social networks, as well as a toll-free number to make donations. Entravision’s 24 Univision affiliate TV stations ran nightly news stories and features on all three days of the campaign.

Children’s Miracle families participated in studio during the three-day event sharing their stories and experiences with Children’s Hospitals, further driving the public interest and donations. The donations collected came in from every single state in the country, including Hawaii and Alaska, and those donations will be earmarked to their local children’s hospitals to help fund critical treatments, healthcare services, pediatric medical equipment and charitable care, as well as to provide treatment to low-income patients. Over the past 14 years, Entravision viewers and listeners have raised more than $28 million for Children’s Miracle Network® Hospitals.

About Children’s Miracle Network Hospitals

Children’s Miracle Network Hospitals® raises funds for 170 children’s hospitals that support the health of 10 million kids each year across the U.S. and Canada. Donations go to local hospitals to fund critical life-saving treatments and healthcare services, along with innovative research, vital pediatric medical equipment, child life services that put kids’ and families’ minds at ease during difficult hospital stays and financial assistance for families who could not otherwise afford these health services. When we improve the health of all children and allow them the opportunity to reach their full potential, we also improve our communities for years to come. Together, we can change kids’ health. Together, we can change the future. To learn about Children’s Miracle Network Hospitals and your local children’s hospital, visit cmnhospitals.org.

About Entravision Communications Corporation

Entravision is a diversified global media, marketing and technology company serving clients throughout the United States and in fast growing population centers in more than 30 countries across Latin America, Europe, Asia and Africa. Our dynamic portfolio of services includes digital, television and radio offerings. Digital, our largest revenue segment, is comprised of five core businesses: Entravision Digital, Smadex, Entravision-Cisneros Interactive, MediaDonuts, and 365 Digital. Entravision Digital provides branding and performance digital solutions to clients and small- and mid-size businesses throughout the world, including the U.S., Latin America and Europe. Smadex provides cutting-edge mobile programmatic solutions and demand-side platforms which enable advertisers to effectively execute performance campaigns using machine-learned bidding algorithms. Entravision-Cisneros Interactive provides unique digital marketing solutions representing major global publishers and ad-tech platforms in Latin America, while also managing the leading digital audio network and solutions player Audio.Ad. MediaDonuts provides digital marketing performance and branding services in the Southeast Asia region and maintains unique commercial partnerships with some of the world’s leading digital publishers and social media platforms. 365 Digital is a digital advertising solutions provider that offers exclusive sales representations with major global platforms in South Africa. Beyond digital, Entravision has 53 television stations and is the largest affiliate group of the Univision and UniMás television networks. Entravision also manages 46 primarily Spanish-language radio stations that feature nationally recognized, Emmy award-winning talent. Shares of Entravision Class A Common Stock trade on the NYSE under ticker: EVC. Learn more about all of our innovative media, marketing and technology offerings at entravision.com or connect with us on social on LinkedIn and Facebook.

Kimberly Esterkin
Addo Investor Relations
evc@addo.com
310-829-5400

Source: Entravision Communications Corporation

Market Index Inclusion and Spikes in a Stocks Demand


Image credit: Liza Summers (Pexels)

Why Investors and Stock Pickers Watch Russell Index Addition Dates

 

A sudden rise in a stock’s price is almost always demand-related. This could occur if the company beats earnings estimates, announces a breakthrough product, is being considered for acquisition from a larger company, or public policy shifts in their favor. Another reason could be inclusion in a major stock market index.

There are investors that look to determine which companies may be added to an index and which may be removed. Although being right doesn’t always mean huge gains for them, the rewards on average make this a legitimate approach for stock picking. One of the more common family of indexes that investors watch is the FTSE Russell indexes. The reason is these are more transparent than others. Russell actually puts out a calendar each year and shares its methodology for including new companies on its website.

The annual rejiggering of the Russell indexes, known as the Russell Reconstitution, is in late Spring and attracts a lot of attention.  Subscribers to Channelchek can expect to receive our notification and analysis on the small-cap Russell 2000 index reconstitution.

 

Abbreviated History of Impactful Companies Added to the Russell after their IPO

Russell updates its indexes quarterly to include new public companies to best represent the market.

 

In addition to the annual index reconstitution, FTSE Russell also has a quarterly calendar where they look at IPOs that occurred during the quarter and weigh the outcomes against their methodology for inclusion in the broad Russell 3000 index. Once in the 3000, companies may be further segmented into other indexes. These inclusions can alter the demand for the stock both immediately, as fund managers seek to mimic an index and buy the stock, and then over time, as index investor demand for the index funds ebb and flow.

 

 

As a testament to just how impactful these additions may be, a recent example involves a company called Society Pass, Inc. (SOPA). Society Pass went public via an IPO in November. On December 20th Russell added new IPOs in order to update the indexes to reflect current markets, and SOPA was added both to the Russell 3000 broad index and the Russell 2000. The average daily trading volume for SOPA leading up to the inclusion was 1.3M, on December 20th, 167.5M shares changed hands. The impact is indicated above in the month-to-date graph (% change). The stock opened at $4.44, traded as high as $13.48, and closed at $11.26. 

 

Opportunity in IPO Additions

Over the last ten years, there have been almost 1500 IPO additions to the Russell Indexes, and the Russell 2000 Small-Cap Index has had the majority of these additions.

 

 

After the Addition

Inclusion in a major index generally results in a higher “base price” for the stock. Further price changes are then more closely tied to fundamentals like company performance.   However, the stock will experience the added transactions that have very little to do with the company and are instead index expectation related. In addition, there should be higher trade volumes and possibly an even higher level of demand because of the company’s increased visibility.

Paul Hoffman

Managing Editor, Channelchek

 

Suggested Reading:



Peter Lynch Echoes Michael Burry’s Warning About Index Investments



The Russell Index Reconstitution, What to Know





Does the Russell Reconstitution Impact Small-Cap Performance During June?



Does Cathie Wood’s ESG Fund Have it Wrong?

 

Sources:

https://content.ftserussell.com/sites/default/files/final_ipo_additions_2021_4_qtr_r3000.pdf

https://www.sec.gov/fast-answers/answersindiceshtm.html

https://budgeting.thenest.com/mutual-funds-safe-against-bad-stock-crash-30572.html

https://content.ftserussell.com/sites/default/files/2021_09_russell_indexes_quarterly_ipo_update.pdf

 

Stay up to date. Follow us:

 

Cannabis Legalization and the Road for Psychedelics


Image credit: Cottonbro (Pexels)

The Cannabis Path to Legalization and its Implications for Psychedelics

 

Federal law has not yet caught up with public sentiment in either the years-old developing cannabis industry or the newer psychedelics space. States have taken the lead and written their own laws. Many have altered state laws to legalize medical and adult-use cannabis, and some have legalized or decriminalized specific psychedelics or entheogens. However, most entheogens and cannabis continue to be stuck as Schedule I narcotics of the CSA. This means that the U.S. has high barriers when it comes to researching these potentially helpful substances.

The cannabis legalization movement has been in the works for decades, and indications are that federal cannabis prohibition will end soon. Comparatively, the current push to legalize psychedelics is in its early stages. What can the cannabis path to legalization tell us about
psychedelics?

 

Background

It took decades for some states to legalize medical and recreational cannabis.  And there still hasn’t been a bill passed at the federal level. At this point, states are taking legalization into their own hands. This may be a desire to get a jump on potential growth in the cannabis industry or even a decision to lower crime statistics. Either way, cannabis is legal in 18 states and decriminalized in 13. Today, the cannabis industry in the U.S. is over $61 billion.

Relatively, the legalization of cannabis is in its infancy. The great strides that were made to make this possible are surely being studied by manufacturers and future proprietors of other recreational drugs.

Psychedelics have emerged as the front runner for the next drug to be accepted and pushed toward legalization. Oregon set precedence last year by decriminalizing personal amounts of ‘hard’ drugs. More and more, people are beginning to believe in harm reduction and dispel notions of mind-altering substances being inherently evil. Psychedelic legalization and nationwide decriminalization are still in the early stages, but it’s beneficial to examine the path cannabis took. After all, it wasn’t an easy road.

 

Medical Benefits Are Important

Before cannabis was legalized in any state, the “wonders” of what cannabis can do for your health was the main talking point for lobbyists. Cataracts, glaucoma, seizures, anxiety disorders, the list goes on and on. It’s not easy to demonize a plant that makes fighting cancer more manageable for patients.

By detailing the extensive list of medical benefits, the concept of cannabis was transformed for the majority of people. Instead of picturing a lazy couch potato, they envisioned a human being in pain and finding relief. Psychedelics would do well to follow the social conditioning cannabis displayed.

Psychedelics have their own medicinal properties. They can significantly reduce feelings of depression, anxiety, and stress. What’s even more amazing is the research that displays that this reduction can last for an extended period of time – years, in some cases. Veterans suffering from PTSD and anyone battling mental health issues can benefit dramatically from these substances. The research into the medical use of Psychedelics is still at its beginning, but the number of companies being formed for Psychedelics leads experts to believe better funding is coming.

 

The Timeline is The Key

Legalized cannabis supporters didn’t give up just because the road was long with no end in sight. As a result, California took the first giant step forward in 1996 when it became the first state to legalize cannabis for medical use. Though a decent number of states followed their lead, it wasn’t until 2012 that Colorado and Washington’s voters made recreational use legal.

These strides for change were good signs, but it still took years for the better part of the nation to agree on one thing – people should not be locked up for possessing personal amounts of cannabis. There are shows and series revolving around cannabis, from cooking with it to different ways of consumption. Incarcerating citizens for a drug that has an entire television market began to make less sense.

Clearer Path

Psychedelics are gaining popularity and support at a much more rapid speed than we saw in the early days of the cannabis movement. Barely a year after Oregon decriminalized psilocybin, a report from The Hill stated that a survey showed that a third of Americans believe ‘magic mushrooms’ have medicinal benefits. The report indicated that 53% of registered voters ages 18-29 believe in the medical capabilities of psychedelic substances, while a large portion of voters over age 30 disagreed.

Understand The Journey Is Not Linear

The path to cannabis legalization was carved out by advocates who stood resolute in their beliefs. At times, it seemed as though if we did see complete legalization, then it would be decades away. Psychedelics are traveling on the road paved by cannabis advocates, but that doesn’t mean the journey will be the exact same or easy. Advocates for the legalization of psychedelics should study what worked and did not work for the cannabis movement while keeping in mind the differences between the two.

Suggested Reading:



Will Investors Experience a Quicker High in Psychedelics as Cannabis Creates the “Model”?



Clarence Thomas Statement on Half-in, Half-out Marijuana Laws





Psychedelic Medicine – The Next Breakthrough in Mental Health Treatment?



From Trippy Drugs to Therapeutic Aids – How Psychedelics Got Their Groove Back

 

 

Sources:

https://today.law.harvard.edu/the-obstacles-to-decriminalizing-psychedelic-drugs-are-political-not-legal-say-experts/

https://greenlightlawgroup.com/blog/what-can-cannabis-legalization-tell-us-about-psychedelics

https://www.ncsl.org/research/health/state-medical-marijuana-laws.aspx

https://flowhub.com/cannabis-industry-statistics#:~:text=The%20U.S.%20cannabis%20industry%20is,level%20salaries%20increased%20in%202020.

https://bjs.ojp.gov/content/pub/pdf/dcjs-nrbjs.pdf

 

Stay up to date. Follow us:

 

Release – Entravision Raises Over $2.1 Million for Childrens Miracle Network Hospitals


Entravision Raises Over $2.1 Million for Children’s Miracle Network Hospitals

 

 

SANTA MONICA, Calif.–(BUSINESS WIRE)– Entravision Communications Corporation (NYSE: EVC), a leading global media and marketing technology company, and Children’s Miracle Network® announced today that together they successfully raised over $2.1 million in the 14th Annual Radiothon event. The Radiothon with the theme “Un Millón Para Los Niños” (One Million for the Children) ran from December 9th through December 11th and was promoted across 34 of Entravision’s owned and operated broadcast stations.

“I would like to extend a sincere thank you to our listeners, personalities and teams at Entravision and Children’s Miracle Network Hospitals for their contributions to this year’s Radiothon,” said Jeffery Liberman, Entravision’s President and Chief Operating Officer. “Entravision takes pride in giving back to our local communities, and we are proud to again work hand-in-hand with Children’s Miracle Network Hospitals to further this mission. We are excited to continue this successful partnership in the future.”

“During a time when our hospitals are struggling with the many challenges brought on by the pandemic, our 14-year partnership with Entravision has proven to be invaluable,” said Danny Garcia, National Director Hispanic Media Partners for Children’s Miracle Network. “These funds will help ensure that local children’s hospitals across the country have the necessary resources to help kids in many communities. Entravision’s amazing team once again delivered by motivating their generous audience and making this Radiothon a total success. I can’t thank Entravision enough for helping us to make miracles happen for local kids!”

Entravision’s 72-hour 2021 Children’s Miracle Network® Radiothon coverage ran on 14 different radio programs, including Erazno y la ChokolataAlex “El Genio” Lucas and El Show del Raton! and El Show de Piolín. Entravision also promoted the Radiothon with a multimedia campaign starting December 2nd which included QR code embedded television and hourly radio promos, display banners, a custom website, social media posts and videos across Entravision Radio and Noticias Ya social networks, as well as a toll-free number to make donations. Entravision’s 24 Univision affiliate TV stations ran nightly news stories and features on all three days of the campaign.

Children’s Miracle families participated in studio during the three-day event sharing their stories and experiences with Children’s Hospitals, further driving the public interest and donations. The donations collected came in from every single state in the country, including Hawaii and Alaska, and those donations will be earmarked to their local children’s hospitals to help fund critical treatments, healthcare services, pediatric medical equipment and charitable care, as well as to provide treatment to low-income patients. Over the past 14 years, Entravision viewers and listeners have raised more than $28 million for Children’s Miracle Network® Hospitals.

About Children’s Miracle Network Hospitals

Children’s Miracle Network Hospitals® raises funds for 170 children’s hospitals that support the health of 10 million kids each year across the U.S. and Canada. Donations go to local hospitals to fund critical life-saving treatments and healthcare services, along with innovative research, vital pediatric medical equipment, child life services that put kids’ and families’ minds at ease during difficult hospital stays and financial assistance for families who could not otherwise afford these health services. When we improve the health of all children and allow them the opportunity to reach their full potential, we also improve our communities for years to come. Together, we can change kids’ health. Together, we can change the future. To learn about Children’s Miracle Network Hospitals and your local children’s hospital, visit cmnhospitals.org.

About Entravision Communications Corporation

Entravision is a diversified global media, marketing and technology company serving clients throughout the United States and in fast growing population centers in more than 30 countries across Latin America, Europe, Asia and Africa. Our dynamic portfolio of services includes digital, television and radio offerings. Digital, our largest revenue segment, is comprised of five core businesses: Entravision Digital, Smadex, Entravision-Cisneros Interactive, MediaDonuts, and 365 Digital. Entravision Digital provides branding and performance digital solutions to clients and small- and mid-size businesses throughout the world, including the U.S., Latin America and Europe. Smadex provides cutting-edge mobile programmatic solutions and demand-side platforms which enable advertisers to effectively execute performance campaigns using machine-learned bidding algorithms. Entravision-Cisneros Interactive provides unique digital marketing solutions representing major global publishers and ad-tech platforms in Latin America, while also managing the leading digital audio network and solutions player Audio.Ad. MediaDonuts provides digital marketing performance and branding services in the Southeast Asia region and maintains unique commercial partnerships with some of the world’s leading digital publishers and social media platforms. 365 Digital is a digital advertising solutions provider that offers exclusive sales representations with major global platforms in South Africa. Beyond digital, Entravision has 53 television stations and is the largest affiliate group of the Univision and UniMás television networks. Entravision also manages 46 primarily Spanish-language radio stations that feature nationally recognized, Emmy award-winning talent. Shares of Entravision Class A Common Stock trade on the NYSE under ticker: EVC. Learn more about all of our innovative media, marketing and technology offerings at entravision.com or connect with us on social on LinkedIn and Facebook.

Kimberly Esterkin
Addo Investor Relations
evc@addo.com
310-829-5400

Source: Entravision Communications Corporation

FAT Brands Inc. (FAT) – Acquisition Closings New Store Openings

Tuesday, December 21, 2021

FAT Brands Inc. (FAT)
Acquisition Closings; New Store Openings

FAT Brands Inc is a multi-brand restaurant franchising company. It develops, markets, and acquires predominantly fast casual restaurant concepts. The company provides turkey burgers, chicken Sandwiches, chicken tenders, burgers, ribs, wrap sandwiches, and others. Its brand portfolio comprises Fatburger, Buffalo’s Cafe and Express, and Ponderosa and Bonanza. The company’s overall footprint covers nearly 32 countries. Fatburger generates maximum revenue for the company.

Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    Fazoli’s and Native Grill. FAT Brands has completed the acquisitions of Italian QSR Fazoli’s and wing concept Native Grill. We anticipate both concepts to see attractive growth. Fazoli’s had an outstanding year with three quarters of record setting sales in 2021, while Native Grill further complements FAT Brands’ existing wing concepts and provides FAT Brands with a larger footprint on the West Coast.

    Arkansas Debut.  Earlier this month, FAT announced the opening of a new co-branded Fatburger and Buffalo’s Express in Greenbrier, Arkansas, under a deal finalized in early 2021. As we have noted in past reports, organic growth is a no cost path for incremental sales and EBITDA growth for FAT Brands …



This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision. 

QuickChek – December 21, 2021



Entravision Raises Over $2.1 Million for Children’s Miracle Network Hospitals

Entravision Communications announced that together with Children’s Miracle Network, they successfully raised over $2.1 million in the 14th Annual Radiothon event

Research, News & Market Data on Entravision Communications

Watch recent presentation from Entravision Communications



Bunker Hill Announces $50 Million Project Finance Package, Mine Purchase, And US EPA Settlement Agreement Amendment

Bunker Hill Mining announced the achievement of its key short-term objectives

Research, News & Market Data on Bunker Hill Mining



Edward G. Atsinger III Transitions to Executive Chairman of the Board of Salem Media Group; David Santrella to Chief Executive Officer and David Evans to Chief Operating Officer

Salem Media Group announces C-Level changes

Research, News & Market Data on Salem Media

Watch recent presentation from Salem Media



Lisa Walker Joins Gevo as Assistant General Counsel

Gevo announced that Lisa Walker has joined Gevo as Assistant General Counsel

Research, News & Market Data on Gevo

Watch recent presentation from Gevo



BioSig Technologies, Inc. Selects Access Strategy Partners to Accelerate Commercial Sales

BioSig Technologies announced that it appointed Access Strategy Partners, Inc. to advise on the next phase of the commercial roll-out

News & Market Data on BioSig Technologies

Watch recent presentation from BioSig Technologies



Capstone Green Energy (NASDAQ:CGRN) to Provide Its 600kW Energy Efficiency System to Alabama Hospital

Capstone Green Energy announced that its central and southern U.S. distributor, Lone Star Power Solutions, has secured a contract to provide a clean energy system to a major hospital in Alabama

Research, News & Market Data on Capstone Green Energy

Watch recent presentation from Capstone Green Energy

 

Stay up to date. Follow us:

 

Indonesia Energy Corp (INDO) – Well Performance Update Has Both Good And Bad News

Tuesday, December 21, 2021

Indonesia Energy Corp (INDO)
Well Performance Update Has Both Good And Bad News

Indonesia Energy Corp Ltd is an oil and gas exploration and production company focused on Indonesia. It holds two oil and gas assets through its subsidiaries in Indonesia: one producing block (the Kruh Block) and one exploration block (the Citarum Block). The Kruh Block is located to the northwest of Pendopo, Pali, South Sumatra. The Citarum Block is located to the south of Jakarta.

Michael Heim, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    Indo released production updates following the completion of Kruh Well 26. On the positive side, the company reports that production has increased 50% with the completion of the well and an earlier well. Production is expected to increase further as the well de-waters. The well came in on budget, and management expects the well to pay for itself within twelve months at current oil prices.

    But there is also bad news.  Unfortunately, management also announced that its Kruh 25 well is currently shut-in as a result of significant damage due to flooding during monsoon rains. The well will be reworked, and we have full expectations it will return to a production level similar to Kruh 26. However, the delay is yet another in a series of issues facing operations. The initial two wells faced …



This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision.